Choy Man, BSc

Clinical Development Director
ViiV Healthcare, Research Triangle Park, NC, USA

Disclosure(s): GlaxoSmithKline: Stocks/Bonds; ViiV Healthcare: Employee

Poster(s):

• 1267 - Efficacy and Safety of Switching to DTG/3TC in Virologically Suppressed PLWH by Age, Including Those Aged ≥65 Years: Pooled Results from the TANGO and SALSA Studies
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET